Results from a bench marking survey on cassette dosing practices in the pharmaceutical industry

被引:0
|
作者
机构
[1] [1,Ackermann, Bradley L.
来源
Ackermann, B.L. (ackermann_bradley_l@lilly.com) | 1600年 / Elsevier Inc.卷 / 15期
关键词
Benchmarking - Mass spectrometry - Synthesis (chemical);
D O I
暂无
中图分类号
学科分类号
摘要
Results from a survey on CD, conducted on behalf of the ASMS Pharmaceutical Interest Group, are presented which provide an assessment of current practices used in the pharmaceutical industry. The purpose of the present report is to disseminate this information, in accordance with a key objective of the Pharmaceutical Interest Group to act as a conduit for benchmark analysis on topics of pharmaceutical interest. Based the level of interaction achieve at the 2003 workshop, it was decided that a similar format would be used in 2004. The topic selected for benchmark analysis is the support of chemical synthesis by MS. In closing, gratitude is expressed towards all who participated in the 2003 workshop.
引用
收藏
相关论文
共 50 条
  • [21] THE RELEVANCE OF HEALTH SERVICES RESEARCH FOR THE PHARMACEUTICAL INDUSTRY IN GERMANY -RESULTS OF A REPRESENTATIVE ONLINE SURVEY
    Anton, V
    Gehrke, K.
    Hessel, F. P.
    VALUE IN HEALTH, 2014, 17 (07) : A414 - A414
  • [22] IMPACT OF PHARMACEUTICAL-INDUSTRY FUNDING ON CLINICAL RESEARCH - RESULTS OF A SURVEY OF ANTIANGINAL TRIALS
    MASSIE, BM
    ROTHENBERG, D
    CLINICAL RESEARCH, 1984, 32 (02): : A298 - A298
  • [23] IMPACT OF PHARMACEUTICAL-INDUSTRY FUNDING OF CLINICAL RESEARCH - RESULTS OF A SURVEY OF ANTIANGINAL TRIALS
    MASSIE, BM
    ROTHENBERG, D
    CIRCULATION, 1984, 70 (04) : 390 - 390
  • [24] Performance and data interpretation of the in vivo comet assay in pharmaceutical industry: EFPIA survey results
    van der Leede, Bas-jan
    Doherty, Ann
    Guerard, Melanie
    Howe, Jonathan
    O'Donovan, Mike
    Plappert-Helbig, Ulla
    Thybaud, Veronique
    MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS, 2014, 775 : 81 - 88
  • [25] Midazolam Indications and Dosing in Palliative Medicine: Results from a Multinational Survey
    Tranung, Morten
    Solheim, Tora Skeidsvoll
    Lohre, Erik Torbjorn
    Marsaa, Kristoffer
    Haugen, Dagny Faksvag
    Laird, Barry
    Thronaes, Morten
    Larsen, Michael Due
    CURRENT ONCOLOGY, 2024, 31 (07) : 4093 - 4104
  • [26] CLINICAL AND REGULATORY PERSPECTIVES ON GENERAL SAFETY PHARMACOLOGY TESTS - RESULTS OF A PHARMACEUTICAL-INDUSTRY SURVEY
    MURPHY, DJ
    GOSSETT, KA
    KERNS, WD
    DRUG DEVELOPMENT RESEARCH, 1995, 35 (03) : 150 - 157
  • [27] The Use of Minipigs for Preclinical Safety Assessment by the Pharmaceutical Industry: Results of an IQ DruSafe Minipig Survey
    Colleton, Curtis
    Brewster, David
    Chester, Anne
    Clarke, David O.
    Heining, Peter
    Olaharski, Andrew
    Graziano, Michael
    TOXICOLOGIC PATHOLOGY, 2016, 44 (03) : 458 - 466
  • [28] Pharmaceutical Industry Perspective on the Non-Clinical Evaluation of Novel Excipients: Results From an Industry Survey Conducted by the IQ Novel Excipient Working Group
    Giffen, Paul S. S.
    Buckley, Lorrene A. A.
    Pinkstaff, Jason
    INTERNATIONAL JOURNAL OF TOXICOLOGY, 2023, 42 (06) : 480 - 488
  • [29] Potentials of the Cultivation of plant Raw Materials in Mecklenburg-Western Pomerania for the pharmaceutical Industry An Online Survey from the Perspective of the pharmaceutical Industry
    Hassel, Angela-Verena
    Schmitz, Mia
    Flessa, Steffen
    Gunther, Sebastian
    Armbruster, Nicole
    ZEITSCHRIFT FUR ARZNEI- & GEWURZPFLANZEN, 2023, 28 (01): : 22 - 27
  • [30] Preliminary results from a survey of multimedia development practices in Australia
    Hannington, Anne
    Reed, Karl
    PRODUCT-FOCUSED SOFTWARE PROCESS IMPROVEMENT, PROCEEDINGS, 2006, 4034 : 192 - 207